Anderson J P, Hughes D C, Park J H. "一种的合成方法" [P]. US Patent, US 11543410 B2, 2021-10-24.
发明人刘建华,何建平,韩伟. "Method for the Synthesis of 5-((o-Tolylthio)methyl)isoxazol-3(2H)-one" [P]. 中国发明专利, 专利号 CN 117589528 A, 授权公告日 2019-06-11.
发明人杨光,黄志刚,韩伟. "A Process for Preparing High-Purity 5-((o-Tolylthio)methyl)isoxazol-3(2H)-one" [P]. 中国发明专利, 专利号 CN 108925158 B, 授权公告日 2024-03-25.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2015, 838, (6), 743-758.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2019, 91, (1), 9787-9805.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of 5-((o-Tolylthio)methyl)isoxazol-3(2H)-one Using HRMS and NMR". J. Chromatogr. A, 2022, 1532, (11), 576-588.
Fischer P, Wagner E. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Molecules, 2020, 601, (8), 3133-3142.